Innovation and Initiatives Audited


The integration of the nutraceuticals specialist InterHealth, acquired by Lonza in September 2016, was one of the main projects in 2017 and was successfully completed in the reporting year. One result of the integration was the expansion and upgrading of the manufacturing site in Fort Smith, AR (USA) for our UC-II undenatured collagen ingredient, a nutritional ingredient clinically proven to benefit consumers by helping to improve joint mobility. It is a key ingredient for many leading brands to develop products in a convenient one-per-day dose.

The other major initiative was the beginning of the integration of Lonza nutritional ingredients and Capsugel formulation and encapsulation capabilities. Capsugel’s strong presence in solutions for the delivery of dietary supplements opens new opportunities for Lonza’s ingredients. Lonza’s penetration in the food and beverage segments represents an opportunity to employ Capsugel’s formulation sciences to improve performance and the consumer experience.

Our Consumer Health and Nutrition business has strong capabilities that play an important role in the development of advanced personal-care products and applications. Overall the hygiene and preservation and the personal-care markets are served globally out of four locations with five different sets of expertise.

  • Biotechnology expertise in Visp (CH)
  • Microbial control and preservation expertise in Allendale, NJ (USA)
  • Microbial control and preservation expertise in Manchester (UK)
  • Hair-care and formulation expertise in Manchester (UK)
  • Skin-care expertise in South Plainfield, NJ (USA)